For decades, intravenous immunoglobulin (IVIg) has provided safe and effective therapy for immunodeficient patients. This proof-of-principle study describes a novel approach to generate personalized IVIg for chronic, antibiotic-resistant infection in real time.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/cid/cix977 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!